Lotus Pharmaceutical Co., Ltd. announced Name of the previous position holder: Arni Hardarson, Resume of the previous position holder: Representative Director of Lotus Pharmaceutical Co., Ltd. Name of the new position holder: Nat Ativitavas, Resume of the new position holder: Director of Innobic (Asia) Company Limited. Reason for the change: Alvogen Emerging Markets Holdings Limited assigned a new representative director. Effective date of the new appointment: 2023/09/04.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
300 TWD | -2.44% | -4.61% | +10.29% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.29% | 2.52B | |
+30.24% | 662B | |
+21.96% | 546B | |
-5.31% | 359B | |
+16.62% | 323B | |
+4.79% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+4.18% | 167B |
- Stock Market
- Equities
- 1795 Stock
- News Lotus Pharmaceutical Co., Ltd.
- Lotus Pharmaceutical Co., Ltd. Announces Director Changes